Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith Mitchell

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of the National Medical Association|February 17, 2024
Executive summary: The role of dairy food intake for improving health among Black Americans across the life continuumKevin Comerford, Yolanda Lawson, Michal Young, et al.
Journal of the National Medical Association|February 20, 2024
The role of dairy food intake for improving health among black Americans across the life continuum: A summary of the evidenceKevin Comerford, Yolanda Lawson, Michal Young, et al.
Journal of Drugs in Dermatology : JDD|April 8, 2025
INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer TherapyJennifer N Choi, Mario Lacouture, Anneke Andriessen, et al.
Cancer|April 22, 2009
Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib studyNadine A Jackson, José Barrueco, Raoudha Soufi-Mahjoubi, et al.
Journal of Surgical Oncology|October 3, 2009
Does diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal cancer? A two-institution reportShayna L Showalter, Ernest L Rosato, P Rani Anne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012Mohammed Mohiuddin, Kathryn Winter, Edith Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2013
Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancerMohammed Mohiuddin, Rebecca Paulus, Edith Mitchell, et al.
World Journal of Urology|August 9, 2023
Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX dataSameh Gomaa, W Kevin Kelly, Edith Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2010
Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?Shannon E Fogh, Anthony Yu, Gregory J Kubicek, et al.
American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of the National Medical Association|February 17, 2024
Executive summary: The role of dairy food intake for improving health among Black Americans across the life continuumKevin Comerford, Yolanda Lawson, Michal Young, et al.
Journal of the National Medical Association|February 20, 2024
The role of dairy food intake for improving health among black Americans across the life continuum: A summary of the evidenceKevin Comerford, Yolanda Lawson, Michal Young, et al.
Journal of Drugs in Dermatology : JDD|April 8, 2025
INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer TherapyJennifer N Choi, Mario Lacouture, Anneke Andriessen, et al.
Cancer|April 22, 2009
Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib studyNadine A Jackson, José Barrueco, Raoudha Soufi-Mahjoubi, et al.
Journal of Surgical Oncology|October 3, 2009
Does diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal cancer? A two-institution reportShayna L Showalter, Ernest L Rosato, P Rani Anne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012Mohammed Mohiuddin, Kathryn Winter, Edith Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2013
Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancerMohammed Mohiuddin, Rebecca Paulus, Edith Mitchell, et al.
World Journal of Urology|August 9, 2023
Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX dataSameh Gomaa, W Kevin Kelly, Edith Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2010
Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?Shannon E Fogh, Anthony Yu, Gregory J Kubicek, et al.
American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.
Pageof 5